Article
Periostin-mediated activation of NF-κB signaling promotes tumor progression and chemoresistance in glioblastoma
22 Apr 2025
Abstract excerpt
Glioblastoma (GBM) is the most aggressive form of diffuse glioma, characterized by high lethality. Temozolomide (TMZ)-based chemotherapy is a standard treatment for GBM, but development of chemoresistance poses a significant therapeutic challenge. Despite advances in understanding GBM biology, the mechanisms driving TMZ resistance remain unclear. Identifying vital molecular players involved in this resistance is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
